Chemistry and bioactivity of food phytoalexins

Bioactive Molecules in Plant Foods

Volumn , Issue , 2012, Pages 111-130

  Udenigwe, Chibuike C ^a   Aluko, Rotimi E ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Functional foods; Human health; Phytoalexins; Phytochemicals

Indexed keywords

EID: 84876315875     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (84)

1. nd edition). Chichester, United Kingdom: John Wiley and Sons.
2. Müller, K. O. and Börger, H. (1940). Experimentelle untersuchungen über die Phytophthora-resistem der kartoffel. Arb. Biologischen Reichsasnstalt Landw. Forstw., 23, 189-231.
3. VanEtten, H. D., Mansfield, J. W., Bailey, J. A. and Farmer, E. E. (1994). Two classes of plant antibiotics: phytoalexins versus phytoanticipins. Plant Cell, 6, 1191-1192.
4. Paxton, J. D. (1980). A new working definition of the term "phytoalexin" Plant Disease, 64, 734.
5. Paxton, J. D. (1981). Phytoalexins-a working redefinition. Journal of Phytopathology, 101, 106-109.
6. Boué, S. M., Cleveland, T. E., Carter-Wientjes, C., Shih, B. Y., Bhatnagar, D., McLachlan, J. M. et al. (2009). Phytoalexin-enriched functional foods, Journal of Agricultural and Food Chemistry, 57, 2614-2622.
7. Darvill, A. G. and Albersheim, P. (1984). Phytoalexins and their elicitors-a defense against microbial infection in plants. Annual Review of Plant Physiology, 35, 243-275.
8. Shattuck, V. I., Yada, R. and Lougheed, E. C. (1988). Ethylene-induced bitterness in stored parsnips. HortScience, 23, 912.
9. Durango, D., Quiňones, W., Torres, F., Rosero, Y., Gil, J. and Echeverri, F. (2002). Phytoalexin accumulation in colombian bean varieties and aminosugars as elicitors. Molecules, 7, 817-832.
10. Pedras, M. S. C. and Ahiahonu, P. W. K. (2005). Metabolism and detoxification of phytoalexins and analogues by phytopathogenic fungi. Phytochemistry, 66, 391-411.
11. Friedman, M. (2006). Potato glycoalkaloids and metabolites: roles in the plant and in the diet. Journal of Agricultural and Food Chemistry, 54, 8655-8681.
12. Baur, J. A. and Sinclair, D. A. (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nature Review Drug Discovery, 5, 493-506.
13. Rimando, A. M., Kalt, W., Magee, J. B., Dewey, J. and Ballington, J. R. (2004). Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. Journal of Agricultural and Food Chemistry, 52, 4713-4719.
14. Udenigwe, C. C., Ramprasath, V. R., Aluko, R. E. and Jones, P. J. H. (2008). Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutrition Reviews, 66, 445-454.
15. Mercolini, L., Saracino, M. A., Bugamelli, F., Ferranti, A., Malaguti, M., Hrelia, S., et al. (2008). HPLC-F analysis of melatonin and resveratrol isomers in wine using an SPE procedure. Journal of Separation Science, 31, 1007-1014.
16. Jeandet, P., Douillet-Breuil, A. C., Bessis, R., Debord, S., Sbaghi, M. and Adrian, M. (2002). Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. Journal of Agricultural and Food Chemistry, 50, 2731-2741.
17. Adrian, M., Jeandet, P., Douillet-Breuil, A. C., Tesson, L. and Bessis, R. (2000). Stilbene content of mature Vitis vinifera berries in response to UV-C elicitation. Journal of Agricultural and Food Chemistry, 48, 6103-6105.
18. Cantos, E., Espín, J. C. and Tomás-Barberán, F. A. (2001). Postharvest induction modeling method using UV irradiation pulses for obtaining resveratrol-enriched table grapes: a new "functional" fruit. Journal of Agricultural and Food Chemistry, 49, 5052-5058.
19. Versari, A., Parpinello, G. P., Tornielli, G. B., Ferrarini, R. and Giulivo, C. (2001). Stilbene compounds and stilbene synthase expression during ripening, wilting, and UV treatment in grape cv. Corvina. Journal of Agricultural and Food Chemistry, 49, 5531-5536.
20. Chung, I. M., Park, M. R., Chun, J. C. and Yun, S. J. (2003). Resveratrol accumulation and resveratrol synthase gene expression in response to abiotic stresses and hormones in peanut plants. Plant Science, 164, 103-109.
21. Potrebko, I. and Resurreccion, A. V. (2009). Effect of ultraviolet doses in combined ultraviolet-ultrasound treatments on trans-resveratrol and trans-piceid contents in sliced peanut kernels. Journal of Agricultural and Food Chemistry, 57, 7750-7756.
22. Bavaresco, L., Petegolli, D., Cantu, E., Fregoni, M., Chiusa, G. and Trevisan, M. (1997). Elicitation and accumulation of stilbene phytoalexins in grapevine berries infected by Botrytis cinerea. Vitis, 36, 77-83.
23. Douillet-Breuil, A.-C., Jeandet, P., Adrian, M. and Bessis, R. (1999). Changes in the phytoalexin content of various Vitis spp. in response to ultraviolet C elicitation. Journal of Agricultural and Food Chemistry, 47, 4456-4461.
24. Langcake, P., Cornford, C. A. and Pryce, R. J. (1979). Identification of pterostilbene as a phytoalexin from Vitis vinifera leaves. Phytochemistry, 18, 1025-1027.
25. Boué, S. M., Carter, C., Ehrlich, K. C. and Cleveland, T. E. (2000). Induction of the soybean phytoalexins coumestrol and glyceollin by Aspergillus. Journal of Agricultural and Food Chemistry, 48, 2167-2172.
26. Boué, S. M., Shih, F. F., Shih, B. Y., Daigle, K. W., Carter-Wienties, C. H. and Cleveland, T. E. (2008). Effects of biotic elicitors on enrichment of antioxidant properties and induced isoflavones in soybean. Journal of Food Science, 73, H43-H49.
27. Kim, H. J., Suh, H. J., Kim, J. H., Kang, S. C., Park, S., Lee, C.H. et al. (2010). Estrogenic activity of glyceollins isolated from soybean elicited with Aspergillus sojae. Journal of Medicinal Food, 13, 382-390.
28. Kim, H. J., Suh, H. J., Kim, J. H., Park, S., Joo, Y. C. and Kim, J. S. (2010). Antioxidant activity of glyceollins derived from soybean elicited with Aspergillus sojae. Journal of Agricultural and Food Chemistry, 58, 11633-11638.
29. Kim, H. J., Suh, H. J., Lee, C. H., Kim, J. H., Kang, S. C., Park, S., et al. (2010). Antifungal activity of glyceollins isolated from soybean elicited with Aspergillus sojae. Journal of Agricultural and Food Chemistry, 58, 9483-9487.
30. Lee, M. R., Kim, J. Y., Chun, J., Park, S., Kim, H.J., Kim, J.-S., et al. (2010). Induction of glyceollins by fungal infection in varieties of Korean soybean. Journal of Microbiology and Biotechnology, 20, 1226-1229.
31. Park, S., Ahn, I. S., Kim, J. H., Lee, M. R., Kim, J. S. and Kim, H. J. (2010). Glyceollins, one of the phytoalexins derived from soybeans under fungal stress, enhance insulin sensitivity and exert insulinotropic actions. Journal of Agricultural and Food Chemistry, 58, 1551-1557.
32. Hammerschmidt, R. (1999). Phytoalexins: what have we learned after 60 years? Annual Review of Phytopathology, 37, 285-306.
33. Boué, S. M., Burow, M. E., Wiese, T. E., Shih, B. Y., Elliott, S., Carter-Wientjes, C. H., et al. (2011). Estrogenic and antiestrogenic activities of phytoalexins from red kidney bean (Phaseolus vulgaris L.). Journal of Agricultural and Food Chemistry, 59, 112-120.
34. Doherty, J. and Buescher, R. (1978). Occurrence of the phytoalexin phaseollin in pods of Phaseolus vulgaris. Journal of the Science of Food and Agriculture, 29, 853-856.
35. Brooks, C. J. W., Watson, D. G. and Freer, I. M. (1986). Elicitation of capsidiol accumulation in suspended callus cultures of Capsicum annuum. Phytochemistry, 25, 1089-1092.
36. Betancourt-Jiménez, M. and Lozoya-Gloria, E. (2008). Local and systemic gene expression of sesquiterpene phytoalexin biosynthetic enzymes in plant leaves. European Journal of Plant Pathology, 121, 439-449.
37. Dewick, P. M. (2002). The biosynthesis of C5-C25 terpenoid compounds. Natural Products Report, 16, 97-130.
38. Jadhav, S. J., Mazza, G. and Salunkhe, D. K. (1991). Terpenoid phytoalexins in potatoes: a review. Food Chemistry, 41, 195-217.
39. Charles, M. T., Mercier, J., Makhlouf, J. and Arul, J. (2008). Physiological basis of UV-C-induced resistance to Botrytis cinerea in tomato fruit. I. Role of pre-and post-challenge accumulation of the phytoalexin-rishitin. Postharvest Biology and Technology, 47, 10-20.
40. Noritake, T., Kawakita, K. and Doke, N. (1996). Nitric oxide induces phytoalexin accumulation in potato tuber tissues. Plant and Cell Physiology, 37, 113-116.
41. Araceli A.-C., Elda C.-M., Edmundo L.-G. and Ernesto G.-P. (2007). Capsidiol production in pepper fruits (Capsicum annuum L.) induced by arachidonic acid is dependent of an oxidative burst. Physiological and Molecular Plant Pathology, 70, 69-76.
42. Lyon, G. D. (1972). Occurrence of rishitin and phytuberin in potato tubers inoculated with Erwinia carotovora var. atroseptica. Physiological Plant Pathology, 2, 411-416.
43. Kodera, Y., Ichikawa, M., Yoshida, J., Kashimoto, N., Uda, N., Sumioka, I., et al. (2002). Pharmacokinetic study of allixin, a phytoalexin produced by garlic. Chemical and Pharmaceutical Bulletin, 50, 354-363.
44. de Lange, D. W. (2007). From red wine to polyphenols and back: A journey through the history of the French Paradox. Thrombosis Research, 119, 403-406.
45. Jang, M., Cai, L., Udeani, C. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
46. Ramprasath, V. R. and Jones, P. J. (2010). Phytosterol and resveratrol: fruit compounds and health effects. Agro Food Industry Hi-Tech., 21, 28-31.
47. Ramprasath, V. R. and Jones, P. J. (2010). Anti-atherogenic effects of resveratrol. European Journal of Clinical Nutrition, 64, 660-668.
48. Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., et al. (2007). Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiology, Biomarkers and Prevention, 16, 1246-1252.
49. Wenzel, E., Soldo, T., Erbersdobler, H. and Somoza, V. (2005). Bioactivity and metabolism of trans-resveratrol orally administered to Wister rats. Molecular Nutrition and Food Research, 49, 482-494.
50. Wenzel, E. and Somoza, V. (2005). Metabolism and bioavailability of trans-resveratrol. Molecular Nutrition and Food Research, 49, 472-481.
51. Benitez, D. A., Pozo-Guisado, E., Alvarez-Barrientos, A., Fernandez-Salguero, P. M. and Castellón, E. A. (2007). Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. Journal of Andrology, 28, 282-293.
52. Bhardwaj, A., Sethi, G., Vadhan-Raj, S., Bueso-Ramos, C., Takada, Y., Gaur, U., et al. (2007). Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factorkB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood, 109, 2293-2302.
53. van Ginkel, P. R., Sareen, D., Subramanian, L., Walker, Q., Darjatmoko, S. R., Lindstrom, M. J., et al. (2007). Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clinical Cancer Research, 13, 5162-5169.
54. Nguyen, A. V., Martinez, M., Stamos, M. J., Moyer, M. P., Planutis, K., Hope, C., et al. (2009). Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Management and Research, 1, 25-37.
55. Das, S. and Das, D. K. (2007). Anti-inflammatory responses of resveratrol. Inflammation and Allergy-Drug Targets, 6, 168-173.
56. Kim, Y. A., Kim, G. Y., Park, K. Y. and Choi, Y. H. (2007). Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysacharideactivated C6 microglia. Journal of Medicinal Food, 10, 218-224.
57. Sharma, S., Chopra, K., Kulkarni, S. K. and Agrewala, J. N. (2007). Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clinical and Experimental Immunology, 147, 155-163.
58. Candelario-Jalil, E., Pinheiro De Oliveira, A.C., Gräf, S., Bhatia, H.S., Hüll, M., Munoz, E., et al. (2007). Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. Journal of Neuroinflammation, 4, 25.
59. Rivera, L., Morón, R., Zarzuelo, A. and Galisteo, M. (2009). Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochemical Pharmacology, 77, 1053-1063.
60. Bradamante, S., Barenghi, L. and Villa, A. (2004). Cardiovascular protective effects of resveratrol. Cardiovascular Drug Reviews, 22, 169-188.
61. Nihei, T., Miura, Y. and Yagasaki, K. (2001). Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats. Life Sciences, 68, 2845-2852.
62. Ahn, J., Cho, I., Kim, S., Kwon, D. and Ha, T. (2008). Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. Journal of Hepatology, 49, 1019-1028.
63. Cho, I. J., Ahn, J. Y., Kim, S., Choi, M. S. and Ha, T. Y. (2008). Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. Biochemical and Biophysical Research Communications, 367, 190-194.
64. Frémont, L. (2000). Minireview: Biological effects of resveratrol. Life Sciences, 66, 663-673.
65. Schneider, J. G., Alosi, J. A., McDonald, D. E. and McFadden, D. W. (2010). Pterostilbene inhibits lung cancer through induction of apoptosis. Journal of Surgical Research, 161, 18-22.
66. Alosi, J. A., McDonald, D. E., Schneider, J. S., Privette, A. R. and McFadden, D.W. (2010). Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. Journal of Surgical Research, 161, 195-201.
67. Park, E.-S., Lim, Y., Hong, J.-T., Yoo, H.-S., Lee, C.-K., Pyo, M.-Y., et al. (2010). Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway. Vascular Pharmacology, 53, 61-67.
68. Chiou, Y.-S., Tsai, M.-L., Wang, Y.-J., Cheng, A.-C., Lai, W.-M., Badmaev, V., et al. (2010). Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice. Journal of Agricultural and Food Chemistry, 58, 8833-8841.
69. Suh, N., Paul, S., Hao, X., Simi, B., Xiao, H., Rimando, A. M. et al. (2007). Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clinical Cancer Research, 13, 350-355.
70. Chen, R., Ho, C. and Wang, Y.-J. (2010). Pterostilbene induces autophagy and apoptosis in sensitive and chemoresistant human bladder cancer cells. Molecular Nutrition and Food Research, 54, 1819-1832.
71. Mannal, P., McDonald, D. and McFadden, D. (2010). Pterostilbene and tamoxifen show an additive effect against breast cancer in vitro. American Journal of Surgery, 200, 577-580.
72. Ferrer, P., Asensi, M., Segarra, R., Ortega, A., Benlloch, M., Obrador, E., et al. (2005). Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia, 7, 37-47.
73. Kapetanovic, I. M., Muzzio, M., Huang, Z., Thompson, T. N. and McCormick, D. L. (2011). Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemotherapy and Pharmacology, 68, 593-601.
74. Burow, M. E., Boue, S. M., Collins-Burow, B. M., Melnik, L. I., Duong, B. N. and Carter-Wientjes, C. H. (2001). Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor α and β. Journal of Clinical Endocrinology and Metabolism, 86, 1750-1758.
75. Salvo, V. A., Boué, S. M., Fonseca, J. P., Elliott, S., Corbitt, C., Collins-Burow, B. M., et al. (2006). Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clinical Cancer Research, 12, 7159-7164.
76. Tilgham, S. L., Boue, S. M. and Burow, M. E. (2010). Glyceollins, a novel class of antiestrogenic phytoalexins. Molecular and Cellular Pharmacology, 2, 155-160.
77. Payton-Stewart, F., Schoene, N. W., Kim, Y.S., Burow, M.E., Cleveland, T.E., Boue, S.M., et al. (2009). Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP. Molecular Carcinogenesis, 48, 862-871.
78. Jung, M. H., Han, S. M., Lee, S. H., Lee, Y. M. and Kim, Y.-H. (2009). Glyceollins protection against vascular endothelial cell death caused by a low-dose proton beam. Korean Journal of Physical Society, 54, 2129-2132.
79. Kodera, Y., Matuura, H., Yoshida, S., Sumida, T., Itakura, Y., Fuwa, T., et al. (1989). Allixin, a stress compound from garlic. Chemical and Pharmaceutical Bulletin, 37, 1656-1658.
80. Moriguchi T., Matsuura H., Itakura Y., Katsuki H., Saito H. and Nishiyama N. (1997). Allixin, a phytoalexin produced by garlic, and its analogues as novel exogenous substances with neurotrophic activity. Life Sciences, 61, 1413-1420.
81. Yamasaki T., Teel R. W. and Lau B. H. S. (1991). Effect of allixin, a phytoalexin produced by garlic, on mutagenesis, DNA-binding and metabolism of aflatoxin Bi. Cancer Letters, 59, 89-94.
82. Nishino, H., Nishino, A., Takayama, J., Iwashima, A., Itakura, Y., Kodera, Y., et al. (1990). Antitumor-promoting activity of allixin, a stress compound produced by garlic. Cancer Journal, 3, 20-21.
83. Lee, K. R., Kozukue, N., Han, J. S., Park, J. H., Chang, E. Y., Baek, E. J., et al. (2004). Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. Journal of Agricultural and Food Chemistry, 52, 2832-2839.
84. Friedman, M., Lee, K. R., Kim, H. J., Lee, I. S. and Kozukue, N. (2005). Anticarcinogenic effects of glycoalkaloids from potatoes against human cervical, liver, lymphoma, and stomach cancer cells. Journal of Agricultural and Food Chemistry, 53, 6162-6169.